- Joined
- Oct 22, 2006
- Messages
- 111
Just FYI:
The American Journal of Gastroenterology
Online Early
doi:10.1111/j.1572-0241.2006.00735.x
Volume 0 Issue 0
CASE REPORT
Cholestatic Jaundice and IgA Nephropathy Induced by OTC Muscle Building Agent Superdrol
, Beata Jasiurkowski, M.D.1, Jaya Raj, M.D.1, David Wisinger, M.D.1, Richard Carlson, M.D.1, Lixian Zou, M.D.1, and Abdul Nadir, M.D.1
Over the counter (OTC) medicines are commonly used in the United States despite a lack of scientific evidence for clinical utility and toxicity associated with their use. A case of jaundice and IgA nephropathy as a consequence of use of a muscle enhancing OTC supplement that was advertised as innocuous with no hormonal activity is described. IgA nephropathy has not been described previously in association with the use of testosterone. The case highlights that, besides adulteration, the misrepresentation of chemicals present in OTC medications and supplements can create confusion and a false sense of security with their use.
(Am J Gastroenterol 2006;101:1–4)
__________________
October 23, 2006:
The American Journal of Gastroenterology
Online Early
doi:10.1111/j.1572-0241.2006.00735.x
Volume 0 Issue 0
CASE REPORT
Cholestatic Jaundice and IgA Nephropathy Induced by OTC Muscle Building Agent Superdrol
, Beata Jasiurkowski, M.D.1, Jaya Raj, M.D.1, David Wisinger, M.D.1, Richard Carlson, M.D.1, Lixian Zou, M.D.1, and Abdul Nadir, M.D.1
Over the counter (OTC) medicines are commonly used in the United States despite a lack of scientific evidence for clinical utility and toxicity associated with their use. A case of jaundice and IgA nephropathy as a consequence of use of a muscle enhancing OTC supplement that was advertised as innocuous with no hormonal activity is described. IgA nephropathy has not been described previously in association with the use of testosterone. The case highlights that, besides adulteration, the misrepresentation of chemicals present in OTC medications and supplements can create confusion and a false sense of security with their use.
(Am J Gastroenterol 2006;101:1–4)
__________________
October 23, 2006: